Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR)

Diabet Med. 2001 Jul;18(7):533-40. doi: 10.1046/j.1464-5491.2001.00496.x.

Abstract

Background: Insulin resistance was found in some but not in all previous studies of non-diabetic first degree relatives of Type 2 diabetic patients. Small study groups, ethnic differences and/or non-optimal techniques may explain the conflicting results.

Aim: To study the impact of a family history of Type 2 diabetes on insulin action in a large group of non-diabetic Europeans using the 'gold standard' euglycaemic hyperinsulinaemic clamp technique.

Methods: Non-diabetic subjects (n = 235) with a positive family history of Type 2 diabetes (FH+) and 564 subjects with no family history of diabetes (FH-) were recruited from The European Group of Insulin Resistance (EGIR) database. This database includes measurements of insulin action using the insulin clamp technique (1 mU/kg per min) in normal glucose-tolerant individuals from 20 different European centres. In a subset of subjects the measurements were performed in combination with indirect calorimetry (n = 80 vs. 213 with and without family history of Type 2 diabetes).

Results: The body mass index (BMI) was slightly higher in FH+ compared with FH- (26.7 +/- 4.6 vs. 25.1 +/- 4.7 kg/m(2); P < 0.02). After correction for covariates according to differences between investigators and subject characteristics including BMI (multiple regression analysis), insulin-stimulated glucose disposal was lower in FH+ compared with FH- (P < 0.00001). Insulin-stimulated glucose oxidation was slightly increased in FH+ compared with FH-, and insulin-stimulated non-oxidative glucose metabolism was consequently markedly reduced in FH+ compared with FH- (P < 0.0005).

Conclusion: Insulin resistance is present in European non-diabetic relatives of Type 2 diabetic patients. The insulin resistance is independent of degree of obesity and is restricted solely to the pathway of non-oxidative glucose metabolism. Diabet. Med. 18, 533-540 (2001)

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism*
  • Body Height
  • Body Mass Index
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / genetics*
  • Energy Metabolism
  • Fasting
  • Fatty Acids, Nonesterified / blood
  • Female
  • Glucose / metabolism
  • Glucose Clamp Technique
  • Glucose Tolerance Test
  • Humans
  • Hyperinsulinism / blood
  • Infusions, Intravenous
  • Insulin / administration & dosage
  • Insulin / blood
  • Insulin / pharmacology*
  • Insulin Resistance / genetics
  • Insulin Resistance / physiology*
  • Liver / metabolism
  • Male
  • Reference Values
  • Regression Analysis
  • Triglycerides / blood

Substances

  • Blood Glucose
  • Cholesterol, HDL
  • Fatty Acids, Nonesterified
  • Insulin
  • Triglycerides
  • Cholesterol
  • Glucose